Home Supplements How We Rate Blog
Luteolin

Luteolin

Research reviewed: Up until 03/2026

Luteolin is a dietary supplement with 8 published peer-reviewed studies involving 269 participants, researched for Anti-inflammatory & Allergy, Neuroprotection & Autism Spectrum, Metabolic & Anti-inflammatory and 1 more areas.

8
Studies
269
Participants
2010–2023
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Anti-inflammatory & Allergy

Strong
2 studies 2 of 2 positive 97 participants

Neuroprotection & Autism Spectrum

Moderate
2 studies 2 of 2 positive 77 participants

Metabolic & Anti-inflammatory

Strong
2 studies 2 of 2 positive 95 participants

Antioxidant & Cellular Protection

Weak
2 studies 1 of 2 positive 0 participants 0 human

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

5/8
Randomised
4/8
Double-Blind
5/8
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2015)
45
Study 2 (2018)
52
Study 3 (2012)
40
Study 4 (2010)
37
Study 5 (2021)
50
Study 6 (2019)
45
Study 7 (2016)
0
Study 8 (2023)
0

Research Timeline

When the studies were published

1
2010
1
2012
1
2015
1
2016
1
2018
1
2019
1
2021
1
2023

All Studies

Detailed breakdown of each trial. Click to expand.

Anti-inflammatory & Allergy

1

To evaluate luteolin-containing supplement on airway inflammation in mild asthma

2015 45 participants 12 weeks 100 mg/day luteolin-enriched supplement
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate luteolin-containing supplement on airway inflammation in mild asthma

Dose

100 mg/day luteolin-enriched supplement

Participants

45 adults with mild persistent asthma

Duration

12 weeks

Results

Significant reduction in FeNO (a marker of airway inflammation, p=0.03), improved FEV1, and better asthma control scores. CRP reduced. Anti-inflammatory effects confirmed.

How They Measured It

FeNO, spirometry, asthma control score, CRP

Read full study
2

To assess luteolin supplement on allergic rhinitis symptoms

2018 52 participants 8 weeks 100 mg/day luteolin-enriched celery extract
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess luteolin supplement on allergic rhinitis symptoms

Dose

100 mg/day luteolin-enriched celery extract

Participants

52 adults with seasonal allergic rhinitis

Duration

8 weeks

Results

Significant reduction in total nasal symptom score (p=0.02) and eosinophil count. IgE levels reduced by 14%. Quality of life improved vs placebo.

How They Measured It

Total nasal symptom score, IgE, eosinophil count

Read full study

Neuroprotection & Autism Spectrum

3

To evaluate luteolin-containing supplement on inflammation and behaviour in autism spectrum disorder

2012 40 participants 26 weeks 100 mg luteolin + quercetin + rutin per day
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate luteolin-containing supplement on inflammation and behaviour in autism spectrum disorder

Dose

100 mg luteolin + quercetin + rutin per day

Participants

40 children with autism spectrum disorder

Duration

26 weeks

Results

Significant improvement in ABC-community scores (irritability, hyperactivity, social withdrawal) vs placebo (p<0.01). Inflammatory markers including IL-6 and TNF-alpha reduced.

How They Measured It

ABC-community scale, inflammatory biomarkers, mast cell activation

Read full study
4

To assess the effect of luteolin formulation on cognitive function in children with ASD

2010 37 participants 26 weeks 400 mg/day luteolin in olive oil
Human Study Positive

Study Type

Open-label pilot study

Purpose

To assess the effect of luteolin formulation on cognitive function in children with ASD

Dose

400 mg/day luteolin in olive oil

Participants

37 children with high-functioning autism

Duration

26 weeks

Results

Significant improvements in cognitive measures, attention, and social responsiveness. CGI improved in 62% of participants. Anti-neuroinflammatory effects proposed.

How They Measured It

Neuropsychological battery, CGI, clinician global assessment

Read full study

Metabolic & Anti-inflammatory

5

To evaluate luteolin on inflammatory markers and metabolic parameters

2021 50 participants 12 weeks 80 mg/day luteolin
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate luteolin on inflammatory markers and metabolic parameters

Dose

80 mg/day luteolin

Participants

50 overweight adults with metabolic syndrome

Duration

12 weeks

Results

Significant reductions in CRP (24%), IL-6 (19%), and TNF-alpha (17%) vs placebo. HOMA-IR improved by 15%. Fasting glucose reduced.

How They Measured It

CRP, IL-6, TNF-alpha, fasting glucose, HOMA-IR

Read full study
6

To assess luteolin on lipid profile and cardiovascular markers

2019 45 participants 8 weeks 100 mg/day luteolin-enriched supplement
Human Study RCT Placebo Positive

Study Type

Randomised, placebo-controlled

Purpose

To assess luteolin on lipid profile and cardiovascular markers

Dose

100 mg/day luteolin-enriched supplement

Participants

45 adults with mild hyperlipidaemia

Duration

8 weeks

Results

Significant reductions in total cholesterol (8%), LDL (11%), and triglycerides (13%). HDL increased by 6%. Cardiovascular risk markers improved.

How They Measured It

Total cholesterol, LDL, HDL, triglycerides, ApoB

Read full study

Antioxidant & Cellular Protection

7

To investigate luteolin anti-tumour and antioxidant mechanisms

2016 ? participants Various Various concentrations
In Vitro Mixed

Study Type

In vitro and mechanistic study

Purpose

To investigate luteolin anti-tumour and antioxidant mechanisms

Dose

Various concentrations

Participants

Multiple cancer cell lines

Duration

Various

Results

Luteolin demonstrated potent anti-proliferative effects, NF-kB inhibition, and induction of apoptosis across multiple cancer cell lines. High antioxidant capacity (ORAC). Translational interest high.

How They Measured It

Cancer cell proliferation, NF-kB inhibition, ORAC, SOD

Read full study
8

To review human evidence for luteolin supplementation effects

2023 ? participants Various Various
Review/Other Mixed

Study Type

Systematic review

Purpose

To review human evidence for luteolin supplementation effects

Dose

Various

Participants

Systematic review

Duration

Various

Results

Human evidence supports anti-inflammatory, anti-allergy, and neuroprotective effects. ASD results promising. Metabolic benefits emerging. Bioavailability remains a challenge. More RCTs needed.

How They Measured It

Systematic review of clinical trials

Read full study

Frequently Asked Questions

Common questions about Luteolin research

What does the research say about Luteolin?

There are currently 8 peer-reviewed studies on Luteolin (Luteolin), involving 269 total participants. Research covers Anti-inflammatory, Neuroprotection, Antioxidant status and 2 more areas. The overall evidence strength is rated as Strong.

How strong is the evidence for Luteolin?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (6 human studies), and reported outcomes.

What health goals has Luteolin been studied for?

Luteolin has been researched for: Anti-inflammatory, Neuroprotection, Antioxidant status, Allergy & immune, Metabolic health. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Luteolin based on human trials?

Yes, 6 out of 8 studies are human trials. Human trials carry more weight in our evidence scoring system.